2[2]Libby P,Ridker PM,Maseri A.Inflammation and atherosclerosis[J].Circulation,2002,105:1135-1143.
3[3]Moghadasian MH.Experimental atherosclemsis a historical overview[J].Life Sci,2002,70:855-865
4[4]Memon RA,Staprans L,Noor M.Infection and inflammation induce LDL oxidation in vivo[J].Arterioscler Thromb Vasc Biol,2000,20(6):536-542.
5[5]Ooni K,Ala-Korpel M.Modified LDL-trigger of atherosclerosis and inflammation in the arterial intima[J].J Inter-Med,2000,247(3):359-370.
6[6]Ooni K,Pentikainen MO,Ala-Korpel M,et al.Aggregation,fusion,and vesicle formation of modified low density lipoprotein particles:molecular mechanisms and effects on matrix interactions[J].J Lipid Res,2000,41:1703-1714.
7[7]Kunjathoor VV,Febbraio M,Podrez EA,et al.Scavenger receptors class A-I/Ⅱ and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages[J].J Biol Chem,2002,277:49982-49988.
10[10]Robert Clarke,David Stansbie.Assessment of homocysteine as a cardiovascular risk factor in clinical practice[J].Ann Clin Biochem,2001,38:624-632.
2[1]Ledru F,Ducimetiere P,Battaglia S,et al.New diagnostic criteria for diabetes and coronary artery disease:insights from an angiographic study.J Am Coll Cardiol,2001,37,1543-1550.
3[2]Law RE,Goetze S,Xi XP,et al.Expression and function of PPARγ in rat and human vascular smooth muscle cells.Circulation,2000,101:1311-1318.
4[3]Ricote M,Li AC,Willson TM,et al.The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation.Nature,1998,391:79-82.
5[4]Inoue M,Itoh H,Tanaka T,et al.Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothehal cells through activation of peroxisome proliferator-activated receptor-γ.Arterioscler Thromb Vasc Biol,2001,21:560-566.
6[5]Watanabe Y,Sunayama S,Shimada K,et al.Troglitazone improves endothelial dysfunction in patients with insulin resistance.J Atheroscler Thromb,2000,7:159-163.
7[6]Wojakowski W,Gminski J.Soluble ICAM-1,VCAM-1 and Eselectin in children from families with high risk of atherosclerosis.Int J Mol Med,2001,7:181-185.
8[7]Mohanty P,Aljada A,Ghanim H,et al.Rosiglitazone improves vascular reactivity,inhibits reactive oxygen species(ROS) generation,reduces p47phox subunit expression in mononuclear cells (MNC) and reduces C reactive protein (CRP) and monocyte chemotactic protein-1 (MCP-1):evidence of a potent anti-inflammatory effect.Diabetes,2001,50(Suppl 2):A68.
9[8]Tellez Gil L,Rosello AM,Collado TA,et al.Modulation of soluble phases of endothelial/leukocyte adhesion molecule 1,intercellular adhesion molecule 1,and vascular cell adhesion molecular 1 with interleukin-1β after experimental endotoxic challenge.Crit Care Med,2001 ,29:776-781.
